Beyond, Inc. appoints Marcus Lemonis as Executive Chairman with performance-based stock option award

BED BATH & BEYOND, INC.

Marcus Lemonis appointed Executive Chairman effective February 20, 2024, having joined the board in October 2023.
He receives a performance-based stock option award for up to 2,250,000 shares with exercise prices of $45, $50, and $60.
Award vests only if Beyond's stock price averages at least $45 (500k shares), $50 (750k), or $60 (1M) over 20 consecutive days.
Stock price rose approximately 72% from $15.04 (Oct 2, 2023) to $25.89 (Feb 16, 2024) since Lemonis joined the board.
No salary or guaranteed equity; award requires stockholder approval at the 2024 annual meeting.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Marcus Lemonis

Executive Chairman

BBBY · BED BATH & BEYOND, INC.

Effective: 2024-02-20
Filed: February 20, 2024, 6:59 PM ET

On February 16, 2024, the Board of Directors (the “Board”) of Beyond, Inc. (“Beyond”) appointed Marcus Lemonis to serve as the Executive Chairman of the Board of Beyond, effective February 20, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Marcus Lemonis was appointed as Executive Chairman at BED BATH & BEYOND, INC..

Action: appointed
Role: Executive Chairman

Exact text from the filing

On February 16, 2024, the Board of Directors (the “Board”) of Beyond, Inc. (“Beyond”) appointed Marcus Lemonis to serve as the Executive Chairman of the Board of Beyond, effective February 20, 2024.

View on SEC.gov

BED BATH & BEYOND, INC. filing history →

Source: SEC EDGAR

accession 0001130713-24-000003

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.